MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
676.51%
Quick Ratio
676.51%
Cash Ratio
647.10%
Debt to Asset Ratio
13.67%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Research and development supplie...
    • Prepaid expenses and other
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Other current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
15,154,203
18,049,255
7,830,855
1,103,315
Prepaid expenses and other
688,632
753,804
525,928
611,786
Total current assets
15,842,835
18,803,059
8,356,783
1,715,101
Property and equipment, net
-
-
0
-
Research and development supplies
1,294,081
1,503,207
1,802,228
1,847,412
Total other assets
1,294,081
1,503,207
1,802,228
1,847,412
Total assets
17,136,916
20,306,266
10,159,011
3,562,513
Accounts payables
293,579
1,655,028
743,070
1,619,446
Derivative liabilities - short term
22,500
-
-
-
Other current liabilities
2,025,785
1,698,468
1,431,565
932,260
Total current liabilities
2,341,864
3,353,496
2,174,635
2,551,706
Derivative liabilities
-
22,500
22,500
243,000
Derivative liabilities - long term
0
-
-
-
Total liabilities
2,341,864
3,375,996
2,197,135
2,794,706
Common stock 0.001 par value 200,000,000 shares authorized 506,218 and 149,811 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
506
9,045
3,291
1,004
Additional paid-in capital
194,732,056
192,411,516
178,986,981
168,004,988
Accumulated deficit
-179,937,510
-175,490,291
-171,028,396
-167,238,185
Total stockholders equity
14,795,052
16,930,270
7,961,876
767,807
Total liabilities and stockholders equity
17,136,916
20,306,266
10,159,011
3,562,513
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$15,154,203 (1025.16%↑ Y/Y)Prepaid expenses andother$688,632 (-2.92%↓ Y/Y)Research and developmentsupplies$1,294,081 (-26.94%↓ Y/Y)Total current assets$15,842,835 (670.50%↑ Y/Y)Total other assets$1,294,081 (-26.94%↓ Y/Y)Total assets$17,136,916 (347.73%↑ Y/Y)Total liabilities andstockholders equity$17,136,916 (347.73%↑ Y/Y)Total stockholdersequity$14,795,052 (963.48%↑ Y/Y)Total liabilities$2,341,864 Accumulated deficit-$179,937,510 (-10.09%↓ Y/Y)Additional paid-in capital$194,732,056 (18.16%↑ Y/Y)Total currentliabilities$2,341,864 (-3.88%↓ Y/Y)Common stock 0.001 parvalue 200,000,000...$506 (-98.47%↓ Y/Y)Other currentliabilities$2,025,785 (34.56%↑ Y/Y)Accounts payables$293,579 (-68.46%↓ Y/Y)Derivative liabilities -short term$22,500

Genprex, Inc. (GNPX)

Genprex, Inc. (GNPX)